General Clinical Study of AJG555 in Pediatric Patients With Chronic Constipation
Status:
Completed
Trial end date:
2017-08-04
Target enrollment:
Participant gender:
Summary
This baseline-controlled, open-label, multicenter study evaluates the efficacy and safety of
AJG555 orally administered for 2 weeks in pediatric participants with chronic constipation.
The safety and efficacy of 12 weeks of administration will also be evaluated.